BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benati M, Montagnana M, Danese E, Mazzon M, Paviati E, Garzon S, Laganà AS, Casarin J, Giudici S, Raffaelli R, Ghezzi F, Franchi M, Lippi G. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer. Pathol Oncol Res 2020;26:2281-9. [PMID: 32462419 DOI: 10.1007/s12253-020-00819-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Karkia R, Wali S, Payne A, Karteris E, Chatterjee J. Diagnostic Accuracy of Liquid Biomarkers for the Non-Invasive Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers 2022;14:4666. [DOI: 10.3390/cancers14194666] [Reference Citation Analysis]
2 Gezer U, Bronkhorst AJ, Holdenrieder S. The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies. Diagnostics 2022;12:1363. [DOI: 10.3390/diagnostics12061363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Markowska A, Chudecka-Głaz A, Pityński K, Baranowski W, Markowska J, Sawicki W. Endometrial Cancer Management in Young Women. Cancers (Basel) 2022;14:1922. [PMID: 35454829 DOI: 10.3390/cancers14081922] [Reference Citation Analysis]
4 Aimagambetova G, Terzic S, Laganà AS, Bapayeva G, la Fleur P, Terzic M. Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients. JCM 2022;11:196. [DOI: 10.3390/jcm11010196] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Terzic M, Aimagambetova G, Bapayeva G, Ukybassova T, Kenbayeva K, Kaiyrlykyzy A, Ibrayimov B, Lyasova A, Terzic S, Alkatout I, Gitas G, Hortu İ, Garzon S, Laganà AS. Pipelle endometrial sampling success rates in Kazakhstani settings: results from a prospective cohort analysis. J Obstet Gynaecol 2021;:1-6. [PMID: 34592892 DOI: 10.1080/01443615.2021.1953452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Terzic M, Aimagambetova G, Kunz J, Bapayeva G, Aitbayeva B, Terzic S, Laganà AS. Molecular Basis of Endometriosis and Endometrial Cancer: Current Knowledge and Future Perspectives. Int J Mol Sci 2021;22:9274. [PMID: 34502183 DOI: 10.3390/ijms22179274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Sun S, Zou L, Wang T, Liu Z, He J, Sun X, Zhong W, Zhao F, Li X, Li S, Zhu H, Ma Z, Wang W, Jin M, Zhang F, Hou X, Wei L, Hu K. Effect of age as a continuous variable in early-stage endometrial carcinoma: a multi-institutional analysis in China. Aging (Albany NY) 2021;13:19561-74. [PMID: 34371481 DOI: 10.18632/aging.203367] [Reference Citation Analysis]
8 Onal C, Sari SY, Yavas G, Guler OC, Yigit E, Oymak E, Gultekin M, Yildiz F. Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy. Future Oncol 2021;17:3321-30. [PMID: 34355983 DOI: 10.2217/fon-2020-1308] [Reference Citation Analysis]
9 Uppuluri L, Jadhav T, Wang Y, Xiao M. Multicolor Whole-Genome Mapping in Nanochannels for Genetic Analysis. Anal Chem 2021;93:9808-16. [PMID: 34232611 DOI: 10.1021/acs.analchem.1c01373] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Strashilov SA, Slavchev S, Kostov S, Yordanov A. First-stage clear-cell endometrial carcinoma with paraaortic lymph node recurrence: a case report. Prz Menopauzalny 2021;20:57-60. [PMID: 33935622 DOI: 10.5114/pm.2021.105273] [Reference Citation Analysis]
11 Liu J, Han L, Jiao Z. The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate. Sci Rep 2021;11:575. [PMID: 33436780 DOI: 10.1038/s41598-020-79960-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Freytag D, Pape J, Dhanawat J, Günther V, Maass N, Gitas G, Laganà AS, Allahqoli L, Meinhold-Heerlein I, Moawad GN, Biebl M, Mettler L, Alkatout I. Challenges Posed by Embryonic and Anatomical Factors in Systematic Lymphadenectomy for Endometrial Cancer. J Clin Med 2020;9:E4107. [PMID: 33352762 DOI: 10.3390/jcm9124107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Pinelli C, Artuso V, Bogani G, Laganà AS, Ghezzi F, Casarin J. Lymph node evaluation in endometrial cancer: how did it change over the last two decades? Transl Cancer Res 2020;9:7778-84. [PMID: 35117380 DOI: 10.21037/tcr-20-2165] [Reference Citation Analysis]
14 Török P, Krasznai Z, Molnár S, Lampé R, Jakab A. Preoperative assessment of endometrial cancer. Transl Cancer Res 2020;9:7746-58. [PMID: 35117377 DOI: 10.21037/tcr-20-2068] [Reference Citation Analysis]
15 Topçu HO, Kaya C, Oral E. Fertility issue in early stage endometrial cancer patients. Transl Cancer Res 2020;9:7797-808. [PMID: 35117382 DOI: 10.21037/tcr-20-2232] [Reference Citation Analysis]
16 Bianco B, Barbosa CP, Trevisan CM, Laganà AS, Montagna E. Endometrial cancer: a genetic point of view. Transl Cancer Res 2020;9:7706-15. [PMID: 35117373 DOI: 10.21037/tcr-20-2334] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lukanović D, Matjašič M, Kobal B. Accuracy of preoperative sampling diagnosis for predicting final pathology in patients with endometrial carcinoma: a review. Transl Cancer Res 2020;9:7785-96. [PMID: 35117381 DOI: 10.21037/tcr-20-2228] [Reference Citation Analysis]
18 Laganà AS. Management of endometrial cancer: current insights and future directions. Transl Cancer Res 2020;9:7685-7. [PMID: 35117370 DOI: 10.21037/tcr-2020-ec-15] [Reference Citation Analysis]
19 Bracco Suarez MB, Benetti-Pinto CL, Gibran L, Yela DA. Asymptomatic postmenopausal women: what are the risk factors for endometrial malignancies? A multicentric retrospective study. Gynecol Endocrinol 2021;37:853-6. [PMID: 33148069 DOI: 10.1080/09513590.2020.1843621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]